Contributed equally to this work with:
Peter H. L. Krijger
Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel
Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Department of Radiation Oncology and Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
Department of Chemistry and Biochemistry, Ludwig Maximilians-University Munich, Munich, Germany
Genome Instability Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America
Chemistry Department, New York University, New York, United States of America
Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan
* E-mail: email@example.com (ZL); firstname.lastname@example.org (HJ)
¶These authors also contributed equally to this work.
This question is to determine if you're a human visitor in order to prevent automated spam
Your submission will be reviewed by our staff.
There was a problem with your submission. Please try again later.